2026 Safety and Availability Communications

This webpage was developed to provide the public with important information about the safety and availability of biological products.

July 2026

• Important Information for Human Cell, Tissue, and Cellular and Tissue-based Product (HCT/P) Establishments Regarding Ebola Disease and HCT/P Donation
  July 10, 2026
• Expiration Date Extension for North American Coral Snake Antivenin (Micrurus fulvius) (Equine Origin) Lot CL6814 through December 31, 2026
  July 1, 2026

June 2026

• Important Information for Blood Establishments Regarding Ebola Disease and Blood Donation
  June 29, 2026

May 2026

• May 20, 2026 Safety Labeling Change Order and SLC Notification Letter - ADZYNMA

March 2026

• Expiration Date Extension for North American Coral Snake Antivenin (Micrurus fulvius) (Equine Origin) Lot CL6814 through June 30, 2026
• Patient and Consumer Warning about Potential Serious Risks of Harm following Use of Unapproved Products from Human Cells or Tissues

January 2026

• January 9, 2026 Safety Labeling Notification Letter - Fluzone
• January 9, 2026 Safety Labeling Notification Letter - Flumist
• January 9, 2026 Safety Labeling Notification Letter - Fluarix
• January 9, 2026 Safety Labeling Notification Letter - Flulaval
• January 9, 2026 Safety Labeling Notification Letter - Afluria
• January 9, 2026 Safety Labeling Notification Letter - Flucelvax